Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2005;9:195–226. doi: 10.1007/0-387-23380-6_12

Endemic mycosis

Chadi A Hage 3, Kenneth S Knox 3, George A Sarosi 3
Editors: Charles Feldman1, George A Sarosi2
PMCID: PMC7120910

The content is available as a PDF (767.4 KB).

References

  • 1.Goodwin R.A., Jr., Des Prez R.M. State of the art: histoplasmosis. Am Rev Respir Dis. 1978;117(5):929–56. doi: 10.1164/arrd.1978.117.5.929. [DOI] [PubMed] [Google Scholar]
  • 2.Sarosi G.A., Davies S.F. Blastomycosis. Am Rev Respir Dis. 1979;120(4):911–38. doi: 10.1164/arrd.1979.120.4.911. [DOI] [PubMed] [Google Scholar]
  • 3.Drutz D.J., Catanzaro A. Coccidioidomycosis. Part I. Am Rev Respir Dis. 1978;117(3):559–85. doi: 10.1164/arrd.1978.117.3.559. [DOI] [PubMed] [Google Scholar]
  • 4.Davies S.F., Khan M., Sarosi G.A. Disseminated histoplasmosis in immunologically suppressed patients. Occurrence in a nonendemic area. Am J Med. 1978;64(1):94–100. doi: 10.1016/0002-9343(78)90183-3. [DOI] [PubMed] [Google Scholar]
  • 5.Goodwin R.A., Jr., et al. Disseminated histoplasmosis: clinical and pathologic correlations. Medicine (Baltimore) 1980;59(1):1–33. [PubMed] [Google Scholar]
  • 6.Manfredi R., et al. Histoplasmosis capsulati and duboisii in Europe: the impact of the HIV pandemic, travel and immigration. Eur J Epidemiol. 1994;10(6):675–81. doi: 10.1007/BF01719280. [DOI] [PubMed] [Google Scholar]
  • 7.Edwards L.B., et al. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis. 1969;99(Suppl):1–132. [PubMed] [Google Scholar]
  • 8.Hammerman K.J., Powell K.E., Tosh F.E. The incidence of hospitalized cases of systemic mycotic infections. Sabouraudia. 1974;12(1):33–45. doi: 10.1080/00362177485380061. [DOI] [PubMed] [Google Scholar]
  • 9.Wheat L.J., et al. A large urban outbreak of histoplasmosis: clinical features. Ann Intern Med. 1981;94(3):331–7. doi: 10.7326/0003-4819-94-3-331. [DOI] [PubMed] [Google Scholar]
  • 10.Wheat L.J., et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990;69(6):361–74. doi: 10.1097/00005792-199011000-00004. [DOI] [PubMed] [Google Scholar]
  • 11.Procknow J.J., Page M.I., Loosli C.G. Early pathogenesis of experimental histoplasmosis. Arch Pathol. 1960;69:413–26. [PubMed] [Google Scholar]
  • 12.Zhou P., Miller G., Seder R.A. Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-alpha plays a critical role in maintaining secondary immunity in the absence of IFN-gamma. J Immunol. 1998;160(3):1359–68. [PubMed] [Google Scholar]
  • 13.Allendoerfer R., Biovin G.P., Deepe G.S., Jr. Modulation of immune responses in murine pulmonary histoplasmosis. J Infect Dis. 1997;175(4):905–14. doi: 10.1086/513989. [DOI] [PubMed] [Google Scholar]
  • 14.Allendorfer R., Brunner G.D., Deepe G.S., Jr. Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J Immunol. 1999;162(12):7389–96. [PubMed] [Google Scholar]
  • 15.Allendoerfer R., Deepe G.S., Jr. Intrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice. Infect Immun. 1997;65(7):2564–9. doi: 10.1128/iai.65.7.2564-2569.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Wood K.L., et al. Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy. Am J Respir Crit Care Med. 2003;167(9):1279–82. doi: 10.1164/rccm.200206-563OC. [DOI] [PubMed] [Google Scholar]
  • 17.Straub M., Schwarz J. The healed primary complex in histoplasmosis. Am J Clin Pathol. 1955;25(7):727–41. doi: 10.1093/ajcp/25.7.727. [DOI] [PubMed] [Google Scholar]
  • 18.Wheat J. Histoplasmosis. Experience during outbreaks in Indianapolis and review of the literature. Medicine (Baltimore) 1997;76(5):339–54. doi: 10.1097/00005792-199709000-00002. [DOI] [PubMed] [Google Scholar]
  • 19.Conces D.J., Jr., et al. Disseminated histoplasmosis in AIDS: findings on chest radiographs. AJR Am J Roentgenol. 1993;160(1):15–9. doi: 10.2214/ajr.160.1.8416614. [DOI] [PubMed] [Google Scholar]
  • 20.Davies S.F., McKenna R.W., Sarosi G.A. Trephine biopsy of the bone marrow in disseminated histoplasmosis. Am J Med. 1979;67(4):617–22. doi: 10.1016/0002-9343(79)90243-2. [DOI] [PubMed] [Google Scholar]
  • 21.Wheat L.J., Slama T.G., Zeckel M.L. Histoplasmosis in the acquired immune deficiency syndrome. Am J Med. 1985;78(2):203–10. doi: 10.1016/0002-9343(85)90427-9. [DOI] [PubMed] [Google Scholar]
  • 22.Johnson P.C., Hamill R.J., Sarosi G.A. Clinical review: progressive disseminated histoplasmosis in the AIDS patient. Semin Respir Infect. 1989;4(2):139–46. [PubMed] [Google Scholar]
  • 23.Wheat L.J., et al. Risk factors for disseminated or fatal histoplasmosis. Analysis of a large urban outbreak. Ann Intern Med. 1982;96(2):159–63. doi: 10.7326/0003-4819-96-2-159. [DOI] [PubMed] [Google Scholar]
  • 24.Sarosi G.A., et al. Disseminated histoplasmosis: results of long-term follow-up. A center for disease control cooperative mycoses study. Ann Intern Med. 1971;75(4):511–6. [Google Scholar]
  • 25.Wheat L.J., Batteiger B.E., Sathapatayavongs B. Histoplasma capsulatum infections of the central nervous system. A clinical review. Medicine (Baltimore) 1990;69(4):244–60. doi: 10.1097/00005792-199007000-00006. [DOI] [PubMed] [Google Scholar]
  • 26.Hawkins S.S., Gregory D.W., Alford R.H. Progressive disseminated histoplasmosis; favorable response to ketoconazole. Ann Intern Med. 1981;95(4):446–9. doi: 10.7326/0003-4819-95-4-446. [DOI] [PubMed] [Google Scholar]
  • 27.Vail G.M., et al. Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis. 2002;4(3):148–51. doi: 10.1034/j.1399-3062.2002.01016.x. [DOI] [PubMed] [Google Scholar]
  • 28.Davies S.F. Serodiagnosis of histoplasmosis. Semin Respir Infect. 1986;1(1):9–15. [PubMed] [Google Scholar]
  • 29.Prechter G.C., Prakash U.B. Bronchoscopy in the diagnosis of pulmonary histoplasmosis. Chest. 1989;95(5):1033–6. doi: 10.1378/chest.95.5.1033. [DOI] [PubMed] [Google Scholar]
  • 30.Wheat L.J., et al. Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid. Am Rev Respir Dis. 1992;145(6):1421–4. doi: 10.1164/ajrccm/145.6.1421. [DOI] [PubMed] [Google Scholar]
  • 31.Salzman S.H., Smith R.L., Aranda C.P. Histoplasmosis in patients at risk for the acquired immunodeficiency syndrome in a nonendemic setting. Chest. 1988;93(5):916–21. doi: 10.1378/chest.93.5.916. [DOI] [PubMed] [Google Scholar]
  • 32.Wheat J., et al. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis. 1997;24(6):1169–71. doi: 10.1086/513647. [DOI] [PubMed] [Google Scholar]
  • 33.Wheat L.J., et al. Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels. Ann Intern Med. 1991;115(12):936–41. doi: 10.7326/0003-4819-115-12-936. [DOI] [PubMed] [Google Scholar]
  • 34.Wheat L.J., et al. Effect of successful treatment with amphotericin B on Histoplasma capsulatum variety capsulatum polysaccharide antigen levels in patients with AIDS and histoplasmosis. Am J Med. 1992;92(2):153–60. doi: 10.1016/0002-9343(92)90106-L. [DOI] [PubMed] [Google Scholar]
  • 35.Dismukes W.E., et al. Itraconazole therapy for blastomycosis and histoplasmosis. Am J Med. 1992;93(5):489–97. doi: 10.1016/0002-9343(92)90575-V. [DOI] [PubMed] [Google Scholar]
  • 36.Wheat J., et al. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1993;118(8):610–6. doi: 10.7326/0003-4819-118-8-199304150-00006. [DOI] [PubMed] [Google Scholar]
  • 37.Hecht P.M., et al. Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16(2):100–7. doi: 10.1097/00042560-199710010-00005. [DOI] [PubMed] [Google Scholar]
  • 38.Goldman, M., et al., Safety of Discontinuation of Maintenance Therapy for Disseminated Histoplasmosis after Immunologic Response to Antiretroviral Therapy: AIDS Clinical Trials Group Study A5038. Clinical Iinfectious Diseases, 2004:38 (15 May). In press. [DOI] [PubMed]
  • 39.Wheat J., et al. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Med. 1995;98(4):336–42. doi: 10.1016/S0002-9343(99)80311-8. [DOI] [PubMed] [Google Scholar]
  • 40.Wheat J., et al. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. Am J Med. 1997;103(3):223–32. doi: 10.1016/s0002-9343(97)00151-4. [DOI] [PubMed] [Google Scholar]
  • 41.Johnson P.C., et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med. 2002;137(2):105–9. doi: 10.7326/0003-4819-137-2-200207160-00008. [DOI] [PubMed] [Google Scholar]
  • 42.Furcolow M.L., et al. Prevalence and incidence studies of human and canine blastomycosis. 1. Cases in the United States, 1885–1968. Am Rev Respir Dis. 1970;102(1):60–7. doi: 10.1164/arrd.1970.102.1.60. [DOI] [PubMed] [Google Scholar]
  • 43.Kepron M.W., et al. North American blastomycosis in Central Canada. A review of 36 cases. Can Med Assoc J. 1972;106(3):243–6. [PMC free article] [PubMed] [Google Scholar]
  • 44.Tosh F.E., et al. A common source epidemic of North American blastomycosis. Am Rev Respir Dis. 1974;109(5):525–9. doi: 10.1164/arrd.1974.109.5.525. [DOI] [PubMed] [Google Scholar]
  • 45.Greenberg S.B. Serious waterborne and wilderness infections. Crit Care Clin. 1999;15(2):387–414. doi: 10.1016/s0749-0704(05)70060-9. [DOI] [PubMed] [Google Scholar]
  • 46.Baumgardner D. J., Brockman K. Epidemiology of human blastomycosis in Vilas County, Wisconsin. II: 1991–1996. Wmj. 1998;97(5):44–7. [PubMed] [Google Scholar]
  • 47.Sarosi G. A., et al. Canine blastomycosis as a harbinger of human disease. Ann Intern Med. 1979;91(5):733–5. doi: 10.7326/0003-4819-91-5-733. [DOI] [PubMed] [Google Scholar]
  • 48.Witorsch P., Utz J.P. North American blastomycosis: a study of 40 patients. Medicine (Baltimore) 1968;47(3):169–200. doi: 10.1097/00005792-196805000-00001. [DOI] [PubMed] [Google Scholar]
  • 49.Klein B.S., et al. Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. N Engl J Med. 1986;314(9):529–34. doi: 10.1056/NEJM198602273140901. [DOI] [PubMed] [Google Scholar]
  • 50.Klein B.S., Vergeront J.M., Davis J.P. Epidemiologic aspects of blastomycosis, the enigmatic systemic mycosis. Semin Respir Infect. 1986;1(1):29–39. [PubMed] [Google Scholar]
  • 51.Abernathy R.S. Clinical manifestations of pulmonary blastomycosis. Ann Intern Med. 1959;51:707–27. doi: 10.7326/0003-4819-51-4-707. [DOI] [PubMed] [Google Scholar]
  • 52.Laskey W., Sarosi G.A. The radiological appearance of pulmonary blastomycosis. Radiology. 1978;126(2):351–7. doi: 10.1148/126.2.351. [DOI] [PubMed] [Google Scholar]
  • 53.Davies S., Sarosi G. Clinical manifestations and management of blastomycosis in the compromised patient. In: Warnock D.W., Richard M.D., editors. Fungal Infection in the Compromised Patient. New York: John Wiley & Sons; 1982. pp. 215–229. [Google Scholar]
  • 54.Pappas P.G., et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1992;116(10):847–53. doi: 10.7326/0003-4819-116-10-847. [DOI] [PubMed] [Google Scholar]
  • 55.Trumbull M.L., Chesney T.M. The cytological diagnosis of pulmonary blastomycosis. Jama. 1981;245(8):836–8. doi: 10.1001/jama.245.8.836. [DOI] [PubMed] [Google Scholar]
  • 56.Martynowicz M.A., Prakash U.B. Pulmonary blastomycosis: an appraisal of diagnostic techniques. Chest. 2002;121(3):768–73. doi: 10.1378/chest.121.3.768. [DOI] [PubMed] [Google Scholar]
  • 57.Lemos L.B., Guo M., Baliga M. Blastomycosis: organ involvement and etiologic diagnosis. A review of 123 patients from Mississippi. Ann Diagn Pathol. 2000;4(6):391–406. doi: 10.1053/adpa.2000.20755. [DOI] [PubMed] [Google Scholar]
  • 58.Gonyea E.F. The spectrum of primary blastomycotic meningitis: a review of central nervous system blastomycosis. Ann Neurol. 1978;3(1):26–39. doi: 10.1002/ana.410030106. [DOI] [PubMed] [Google Scholar]
  • 59.Kravitz G.R., et al. Chronic blastomycotic meningitis. Am J Med. 1981;71(3):501–5. doi: 10.1016/0002-9343(81)90189-3. [DOI] [PubMed] [Google Scholar]
  • 60.Flynn N.M., et al. An unusual outbreak of windborne coccidioidomycosis. N Engl J Med. 1979;301(7):358–61. doi: 10.1056/NEJM197908163010705. [DOI] [PubMed] [Google Scholar]
  • 61.Werner S.B., et al. An epidemic of coccidioidomycosis among archeology students in northern California. N Engl J Med. 1972;286(10):507–12. doi: 10.1056/NEJM197203092861003. [DOI] [PubMed] [Google Scholar]
  • 62.Drutz D.J., Catanzaro A. Coccidioidomycosis. Part II. Am Rev Respir Dis. 1978;117(4):727–71. doi: 10.1164/arrd.1978.117.4.727. [DOI] [PubMed] [Google Scholar]
  • 63.Bouza E., et al. Coccidioidal meningitis. An analysis of thirty-one cases and review of the literature. Medicine (Baltimore) 1981;60(3):139–72. [PubMed] [Google Scholar]
  • 64.Bayer A.S., et al. Unusual syndromes of coccidioidomycosis: diagnostic and therapeutic considerations; a report of 10 cases and review of the English literature. Medicine (Baltimore) 1976;55(2):131–52. doi: 10.1097/00005792-197603000-00003. [DOI] [PubMed] [Google Scholar]
  • 65.Bayer A.S. Fungal pneumonias; pulmonary coccidioidal syndromes (Part I). Primary and progressive primary coccidioidal pneumonias — diagnostic, therapeutic, and prognostic considerations. Chest. 1981;79(5):575–83. doi: 10.1378/chest.79.5.575. [DOI] [PubMed] [Google Scholar]
  • 66.Winn W.A. A long term study of 300 patients with cavitary-abscess lesions of the lung of coccidioidal origin. An analytical study with special reference to treatment. Dis Chest. 1968;54(Suppl1):268+. doi: 10.1378/chest.54.supplement_1.268. [DOI] [PubMed] [Google Scholar]
  • 67.Rutala P.J., Smith J.W. Coccidioidomycosis in potentially compromised hosts: the effect of immunosuppressive therapy in dissemination. Am J Med Sci. 1978;275(3):283–95. doi: 10.1097/00000441-197805000-00006. [DOI] [PubMed] [Google Scholar]
  • 68.Cohen I.M., et al. Coccidioidomycosis in renal replacement therapy. Arch Intern Med. 1982;142(3):489–94. doi: 10.1001/archinte.142.3.489. [DOI] [PubMed] [Google Scholar]
  • 69.Blair J.E., Douglas D.D., Mulligan D.C. Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area. Transpl Infect Dis. 2003;5(1):3–8. doi: 10.1034/j.1399-3062.2003.00005.x. [DOI] [PubMed] [Google Scholar]
  • 70.Bronnimann D.A., et al. Coccidioidomycosis in the acquired immunodeficiency syndrome. Ann Intern Med. 1987;106(3):372–9. doi: 10.7326/0003-4819-106-3-372. [DOI] [PubMed] [Google Scholar]
  • 71.Fish D.G., et al. Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine (Baltimore) 1990;69(6):384–91. doi: 10.1097/00005792-199011000-00006. [DOI] [PubMed] [Google Scholar]
  • 72.Warlick M.A., Quan S.F., Sobonya R.E. Rapid diagnosis of pulmonary coccidioidomycosis. Cytologic v potassium hydroxide preparations. Arch Intern Med. 1983;143(4):723–5. doi: 10.1001/archinte.143.4.723. [DOI] [PubMed] [Google Scholar]
  • 73.Wallace J.M., et al. Flexible fiberoptic bronchoscopy for diagnosing pulmonary coccidioidomycosis. Am Rev Respir Dis. 1981;123(3):286–90. doi: 10.1164/arrd.1981.123.3.286. [DOI] [PubMed] [Google Scholar]
  • 74.Polesky A., et al. Airway coccidioidomycosis—report of cases and review. Clin Infect Dis. 1999;28(6):1273–80. doi: 10.1086/514778. [DOI] [PubMed] [Google Scholar]
  • 75.Mahaffey K.W., et al. Unrecognized coccidioidomycosis complicating Pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus and treated with corticosteroids. A report of two cases. Arch Intern Med. 1993;153(12):1496–8. doi: 10.1001/archinte.153.12.1496. [DOI] [PubMed] [Google Scholar]
  • 76.Sobonya R.E., et al. Detection of fungi and other pathogens in immunocompromised patients by bronchoalveolar lavage in an area endemic for coccidioidomycosis. Chest. 1990;97(6):1349–55. doi: 10.1378/chest.97.6.1349. [DOI] [PubMed] [Google Scholar]
  • 77.Sarosi G.A., et al. Rapid diagnostic evaluation of bronchial washings in patients with suspected coccidioidomycosis. Semin Respir Infect. 2001;16(4):238–41. doi: 10.1053/srin.2001.29323. [DOI] [PubMed] [Google Scholar]
  • 78.Standard P.G., Kaufman L. Immunological procedure for the rapid and specific identification of Coccidioides immitis cultures. J Clin Microbiol. 1977;5(2):149–53. doi: 10.1128/jcm.5.2.149-153.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Smith C.E., Saito M.T., Simons S. A. Pattern of 39,500 serologic tests in coccidioidomycosis. J Am Med Assoc. 1956;160(7):546–52. doi: 10.1001/jama.1956.02960420026008. [DOI] [PubMed] [Google Scholar]
  • 80.Galgiani J.N., et al. Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America. Clin Infect Dis. 2000;30(4):658–61. doi: 10.1086/313747. [DOI] [PubMed] [Google Scholar]
  • 81.Bennett J.E. Chemotherapy of systemic mycoses (first of two parts) N Engl J Med. 1974;290(1):30–2. doi: 10.1056/NEJM197401032900107. [DOI] [PubMed] [Google Scholar]
  • 82.Galgiani J.N., et al. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Ann Intern Med. 2000;133(9):676–86. doi: 10.7326/0003-4819-133-9-200011070-00009. [DOI] [PubMed] [Google Scholar]
  • 83.Diamond R.D., Bennett J.E. A subcutaneous reservoir for intrathecal therapy of fungal meningitis. N Engl J Med. 1973;288(4):186–8. doi: 10.1056/NEJM197301252880405. [DOI] [PubMed] [Google Scholar]
  • 84.Dewsnup D.H., et al. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? Ann Intern Med. 1996;124(3):305–10. doi: 10.7326/0003-4819-124-3-199602010-00004. [DOI] [PubMed] [Google Scholar]

Articles from Tropical and Parasitic Infections in the Intensive Care Unit are provided here courtesy of Nature Publishing Group

RESOURCES